Professional article
OA Policy
English

Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland

Published in

Schweizerische medizinische Wochenschrift, vol. 145, w14100

Publication date

2015

Abstract

The availability of drugs such as thalidomide, bortezomib and lenalidomide changed the landscape in myeloma treatment and has extended the median survival up to 10 years with a substantial improvement in quality of life. This development prompted a Swiss expert panel to re-evaluate the current status and formulate updated clinical recommendations for the diagnosis and treatment of plasma cell myeloma. These recommendations should help clinicians in their decision making to achieve the best outcome based on currently available data.

Citation (ISO format)

SAMARAS, Panagiotis et al. Current status and updated recommendations for diagnosis and treatment of plasma cell myeloma in Switzerland. In: Schweizerische medizinische Wochenschrift, 2015, vol. 145, p. w14100. doi: 10.4414/smw.2015.14100

Main files (1)

Article (Published version)

Identifiers

Journal ISSN

0036-7672
572views
780downloads

Technical informations

Creation

25/11/2015 13:44:00

First validation

25/11/2015 13:44:00

Update

15/03/2023 00:05:37

Status update

15/03/2023 00:05:36

Last indexation

31/10/2024 02:36:04
All rights reserved by Archive ouverte UNIGE and the University of Geneva
OpenAIRE Indexed & Validated